This indicates that the up-regulation of TNXB, in patients with advanced stage of ovarian cancer, might induce low expression of MMP2 and MMP9. The decrease of MMP2 has been reported in liver metastases in advanced colorectal cancers [27]. Here, TNXB is linked to ovarian cancer.